IMC Chicago’s ProShares UltraShort Health Care RXD Stock Holding History

IMC Chicago’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$209K	Buy	+10,291	New	+$190K	﹤0.01%	4972
2025 Q3	–	Sell	-11,176	Closed	-$270K	–	3840
2025 Q2	$271K	Buy	+11,176	New	+$273K	﹤0.01%	3154
2024 Q2	–	Sell	-12,181	Closed	-$267K	–	2770
2024 Q1	$248K	Buy	+12,181	New	+$265K	﹤0.01%	2282
2023 Q3	–	Sell	-8,602	Closed	-$216K	–	1637
2023 Q2	$213K	Buy	+8,602	New	+$218K	﹤0.01%	1274

Other funds holding RXD

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IMC Chicago's RXD Position: Q1 2026 in Review

IMC Chicago opened a new position in ProShares UltraShort Health Care (RXD) in Q1 2026: 10,291 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #4972 among its holdings. This is a return to the name: IMC Chicago previously reported a position in RXD as recently as Q2 2025.

IMC Chicago first reported a position in RXD in Q2 2023 and has held it in 4 quarters since. The position peaked at $271K in Q2 2025. 5 funds tracked by Wall St. Rank hold RXD as of Q1 2026.

IMC Chicago held 10,291 shares of ProShares UltraShort Health Care worth $209K as of Q1 2026.
ProShares UltraShort Health Care was a new IMC Chicago position in Q1 2026.
ProShares UltraShort Health Care made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4972 holding.
IMC Chicago first reported a position in ProShares UltraShort Health Care in Q2 2023 and has held it in 4 quarters since.
IMC Chicago's ProShares UltraShort Health Care position peaked at $271K in Q2 2025.
5 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.